Abstract
Objective. - To evaluate triptan use patterns in a large Israeli HMO district. Background. - Triptans, 5HT1B/1D agonists, provide an effective and safe relief of headache and accompanying symptoms during an acute migraine attack. Method. - We retrospectively reviewed the computerized prescription filling data of 1498 patients who filled a first triptan prescription between July 2003 and June 2004. Results. - During a 1-year follow-up period, 841 patients (56.1%) purchased triptans only once. Single-time users were significantly more prevalent among men and in patients younger than 30 or older than 70 years. Conclusions. - It seems that many migraine patients choose not to use triptans after their first experience with the drug.
| Original language | English |
|---|---|
| Pages (from-to) | 1261-1263 |
| Number of pages | 3 |
| Journal | Headache |
| Volume | 46 |
| Issue number | 8 |
| DOIs | |
| State | Published - 1 Sep 2006 |
Keywords
- Compliance
- Patient education
- Patient's decision making
- Triptans
ASJC Scopus subject areas
- Neurology
- Clinical Neurology